CD34 and chronic myelogenous leukemia, BCR-ABL1 positive: Activation of p38 MAPK has been shown to be responsible for IFNa-induced growth inhibition in IFNa-sensitive CML cells [22] as well as in primary CD34+ cells from PV patients [23].